Detalhe da pesquisa
1.
AXL/MERTK inhibitor ONO-7475 potently synergizes with venetoclax and overcomes venetoclax resistance to kill FLT3-ITD acute myeloid leukemia.
Haematologica
; 107(6): 1311-1322, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34732043
2.
Two Cases of Possible Familial Chronic Myeloid Leukemia in a Family with Extensive History of Cancer.
Acta Haematol
; 144(5): 585-590, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33735874
3.
Thirty-three years later: Two distinct cases of acute lymphoblastic leukemia in one patient.
Am J Hematol
; 95(9): 1117-1120, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32356323
4.
Targeting the NRF2/HO-1 Antioxidant Pathway in FLT3-ITD-Positive AML Enhances Therapy Efficacy.
Antioxidants (Basel)
; 11(4)2022 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35453402
5.
Heterogeneous nuclear ribonucleoprotein K is overexpressed in acute myeloid leukemia and causes myeloproliferation in mice via altered Runx1 splicing.
NAR Cancer
; 4(4): zcac039, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36518526
6.
Prognostic and therapeutic implications of measurable residual disease in acute myeloid leukemia.
J Hematol Oncol
; 14(1): 137, 2021 09 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34479626
7.
The Eµ-hnRNP K Murine Model of Lymphoma: Novel Insights into the Role of hnRNP K in B-Cell Malignancies.
Front Immunol
; 12: 634584, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33912162
8.
Overexpression of CD200 is a Stem Cell-Specific Mechanism of Immune Evasion in AML.
J Immunother Cancer
; 9(7)2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34326171
9.
Uncovering the Role of RNA-Binding Protein hnRNP K in B-Cell Lymphomas.
J Natl Cancer Inst
; 112(1): 95-106, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31077320
10.
Emerging treatment options for patients with p53-pathway-deficient CLL.
Ther Adv Hematol
; 10: 2040620719891356, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31839919
11.
Antileukemia Effects of Notch-Mediated Inhibition of Oncogenic PLK1 in B-Cell Acute Lymphoblastic Leukemia.
Mol Cancer Ther
; 18(9): 1615-1627, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31227645